Panostaja Oyj
Panostaja Oyj Managers' Transactions
Panostaja Oyj Stock Exchange Bulletin, Managers´ Transactions March 17, 2021 at 16:45 pm.
| Person subject to the notification requirement | ||
| Name: | Eriksson, Eero | |
| Position: | Member of the Board/Deputy member | |
| Initial Notification | ||
| Reference number: | 743700ZGH7GD27UOQO12_20210317122343_29 | |
| Issuer | ||
| Name: | Panostaja Oyj | |
| LEI: | 743700ZGH7GD27UOQO12 | |
| Transaction details | ||
| Transaction date: | 2021-03-17 | |
| Venue: | NASDAQ HELSINKI LTD (XHEL) | |
| Nature of the transaction: | Receipt of a Share-Based Incentive or Remuneration | |
| Instrument: | Share | |
| ISIN: | FI0009800379 | |
| Volume: | 2703 | |
| Unit price: | 0,00000 Euro | |
| Aggregated transactions | ||
| Volume: | 2703 | |
| Volume weighted average price: | 0.00000 Euro | |
PANOSTAJA OYJ
For further information, contact CEO Tapio Tommila: tel. +358 (0)40-527 6311
www.panostaja.fi/en/
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Robex Resources Inc.13.12.2025 06:31:43 CET | Press release
Robex Files Addendum to Information Circular in Connection With Amendment to Arrangement Agreement With Predictive Discovery
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva Releases Q4 2025 Aide Memoire
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Ingredion Incorporated12.12.2025 22:06:36 CET | Press release
Ingredion Incorporated Declares Quarterly Dividend of $0.82 Per Share
Aspo Plc12.12.2025 17:30:00 CET | Press release
Aspo Plc: Share repurchase 12.12.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
